Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Proto Labs PRLB Stock Downside Risk Overview Q4 2025 Profit Exceeds Views Is Chiron XRN stock a smart buy at current levels In Focus 20260422 GameSquare Holdings GAME Stock Growth Potential Overhead Buying 20260420 What PLDT Inc PHI is doing to stay ahead Neutral 20260511 IGC Pharma IGC Stock Why Competitive Advantage Slight Downtick 20260422 AXGN Axogen Q4 2025 EPS falls nearly 30 percent short of estimates shares post modest gain today American Tower Corporation AMT Mixed Brokerage Ratings Underscore Compelling RiskReward For HighYield Dividend Investors ALRM Alarmcom Q4 2025 EPS beats estimates by 101 percent shares edge marginally lower in trading today Versamet VMET crushes estimates as EPS shatters forecasts revenue surges 189 YoY yet shares slip 126 Alto Neuro ANRO Declines 619 Amid Market Weakness 20260519 Paychex PAYX Up 258 Is There More Room to Run 20260518 SpaceX Eyes RecordBreaking 175 Trillion IPO as Musk Prepares to Take Rocket and AI Empire Public Foxconn Optimistic on Q2 Outlook as AI Boom Offsets Seasonal and Geopolitical Headwinds Uxin Limited UXIN Falls Sharply as Selling Pressure Intensifies Thermo TMO Rallies 089 as Bulls Target 47438 20260520 Constellium CSTM Crushes Q1 2026 Estimates EPS 142 Tops Views Bilibili Maintains Strong Gen Z Engagement with 119 Minutes Daily User Time SEAT Q1 2026 Earnings EPS Miss Widens Loss as Revenue Data Unavailable CC Q1 2026 Earnings Surprise Profit Beats Estimates by Wide Margin ALIT Q1 2026 Earnings EPS Surprises 34 Above Estimates Stock Edges Higher BXP Q1 2026 Earnings Massive EPS Beat Highlights Operational Resilience KGEI Q1 2026 Earnings EPS Misses Expectations Stock Declines 82 Edwards Lifesciences EW Slips 126 Amid Sector Headwinds Testing Key Support Levels TONX Drops 94 as Selling Pressure Intensifies Nears Critical Support Steel Dynamics STLD Gains 35 as Steel Sector Momentum Builds Castle Biosciences Slides 208 as Shares Test Support Near 1973